$PPSI
PIONEER POWER SOLUTIONS, INC.

2023 Q4 Form 10-Q Financial Statement

#000149315223041076 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $8.413M $12.44M
YoY Change -11.67% 99.06%
Cost Of Revenue $8.698M $8.732M
YoY Change 28.59% 62.0%
Gross Profit -$285.0K $3.711M
YoY Change -110.33% 331.01%
Gross Profit Margin -3.39% 29.82%
Selling, General & Admin $2.115M $2.758M
YoY Change 5.75% 19.65%
% of Gross Profit 74.32%
Research & Development $885.0K
YoY Change
% of Gross Profit
Depreciation & Amortization $82.00K $143.0K
YoY Change -53.41% 257.5%
% of Gross Profit 3.85%
Operating Expenses $3.000M $2.758M
YoY Change 50.0% 19.65%
Operating Profit -$3.285M $953.0K
YoY Change -532.24% -166.0%
Interest Expense $40.00K $60.00K
YoY Change -72.22% -48.28%
% of Operating Profit 6.3%
Other Income/Expense, Net $520.0K $11.00K
YoY Change 1081.82% -35.29%
Pretax Income -$2.725M $1.024M
YoY Change -387.45% -178.11%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$2.725M $1.024M
YoY Change -387.45% -178.11%
Net Earnings / Revenue -32.39% 8.23%
Basic Earnings Per Share $0.10
Diluted Earnings Per Share -$0.27 $0.10
COMMON SHARES
Basic Shares Outstanding 9.930M shares 10.01M shares
Diluted Shares Outstanding 10.25M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.582M $7.581M
YoY Change -65.21% 5.15%
Cash & Equivalents $3.582M $7.581M
Short-Term Investments
Other Short-Term Assets $7.512M $5.518M
YoY Change 163.3% 556.9%
Inventory $7.579M $8.280M
Prepaid Expenses
Receivables $9.010M $8.936M
Other Receivables $0.00 $0.00
Total Short-Term Assets $27.68M $30.32M
YoY Change -16.2% 14.61%
LONG-TERM ASSETS
Property, Plant & Equipment $3.899M $3.775M
YoY Change -1.96% 375.44%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $82.00K $82.00K
YoY Change -49.38% -2.38%
Total Long-Term Assets $5.339M $5.446M
YoY Change 28.99% 81.9%
TOTAL ASSETS
Total Short-Term Assets $27.68M $30.32M
Total Long-Term Assets $5.339M $5.446M
Total Assets $33.02M $35.76M
YoY Change -11.17% 21.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.396M $4.961M
YoY Change -34.96% 44.51%
Accrued Expenses $7.213M $4.811M
YoY Change 344.15% 277.93%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $139.0K $157.0K
YoY Change -60.85% -55.27%
Total Short-Term Liabilities $18.26M $16.61M
YoY Change -3.69% 35.08%
LONG-TERM LIABILITIES
Long-Term Debt $278.0K $320.0K
YoY Change -33.49% -31.91%
Other Long-Term Liabilities $49.00K $53.00K
YoY Change -96.17% -95.94%
Total Long-Term Liabilities $49.00K $53.00K
YoY Change -96.17% -95.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $18.26M $16.61M
Total Long-Term Liabilities $49.00K $53.00K
Total Liabilities $18.80M $17.26M
YoY Change -7.1% 26.9%
SHAREHOLDERS EQUITY
Retained Earnings -$19.63M -$15.12M
YoY Change 23.07% -10.5%
Common Stock $10.00K $10.00K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $14.22M $18.50M
YoY Change
Total Liabilities & Shareholders Equity $33.02M $35.76M
YoY Change -11.17% 21.45%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$2.725M $1.024M
YoY Change -387.45% -178.11%
Depreciation, Depletion And Amortization $82.00K $143.0K
YoY Change -53.41% 257.5%
Cash From Operating Activities -$3.667M -$598.0K
YoY Change 114.44% -74.17%
INVESTING ACTIVITIES
Capital Expenditures $151.0K $1.535M
YoY Change -86.53% -807.37%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$151.0K -$1.535M
YoY Change -102.95% 607.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -181.0K 88.00K
YoY Change -42.9% -304.65%
NET CHANGE
Cash From Operating Activities -3.667M -598.0K
Cash From Investing Activities -151.0K -1.535M
Cash From Financing Activities -181.0K 88.00K
Net Change In Cash -3.999M -2.045M
YoY Change -229.59% -20.58%
FREE CASH FLOW
Cash From Operating Activities -$3.667M -$598.0K
Capital Expenditures $151.0K $1.535M
Free Cash Flow -$3.818M -$2.133M
YoY Change 34.86% 1.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001449792
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q4 us-gaap Deferred Costs
DeferredCosts
usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
usd
PPSI Amortization Of Imputed Interest
AmortizationOfImputedInterest
usd
us-gaap Other Noncash Income
OtherNoncashIncome
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
usd
PPSI Acquisition Of Right Of Use Assets And Lease Liabilities
AcquisitionOfRightOfUseAssetsAndLeaseLiabilities
usd
PPSI Deferred Financing Costs Included In Accounts Payable And Accrued Liabilities
DeferredFinancingCostsIncludedInAccountsPayableAndAccruedLiabilities
usd
PPSI Surrender And Retirement Of Common Stock
SurrenderAndRetirementOfCommonStock
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
PPSI Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Forfeited
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited
usd
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35212
dei Entity Registrant Name
EntityRegistrantName
PIONEER POWER SOLUTIONS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-1347616
dei Entity Address Address Line1
EntityAddressAddressLine1
400 Kelby Street
dei Entity Address Address Line2
EntityAddressAddressLine2
12th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
Fort Lee
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07024
dei City Area Code
CityAreaCode
(212)
dei Local Phone Number
LocalPhoneNumber
867-0700
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
PPSI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9930022 shares
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12443000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6251000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33080000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17476000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8732000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5390000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
24445000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
15629000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
3711000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
861000 usd
us-gaap Gross Profit
GrossProfit
8635000 usd
us-gaap Gross Profit
GrossProfit
1847000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2758000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2305000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8004000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6636000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
2758000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
2305000 usd
us-gaap Operating Expenses
OperatingExpenses
8004000 usd
us-gaap Operating Expenses
OperatingExpenses
6636000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
953000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1444000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
631000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4789000 usd
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
60000 usd
CY2022Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
116000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
192000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
322000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
17000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-112000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1024000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1311000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
827000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4579000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1024000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1311000 usd
us-gaap Net Income Loss
NetIncomeLoss
827000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4586000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.47
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10010226 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9769545 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9896850 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9713335 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10250099 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9769545 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10049009 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9713335 shares
CY2023Q3 us-gaap Cash
Cash
7581000 usd
CY2022Q4 us-gaap Cash
Cash
10296000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8936000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11139000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
8280000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
8748000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5518000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2853000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
30315000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
33036000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3775000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1800000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
936000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1450000 usd
CY2023Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
458000 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
727000 usd
CY2023Q3 us-gaap Deferred Costs
DeferredCosts
195000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
82000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
162000 usd
CY2023Q3 us-gaap Assets
Assets
35761000 usd
CY2022Q4 us-gaap Assets
Assets
37175000 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
9772000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7239000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
704000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
703000 usd
CY2023Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
157000 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
355000 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
5980000 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
10665000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
16613000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
18962000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
276000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
797000 usd
CY2023Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
320000 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
418000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
53000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
65000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
17262000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
20242000 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9930022 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9930022 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9644545 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9644545 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
10000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
10000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
33612000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
32859000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
14000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15123000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15950000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
18499000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
16933000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
35761000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
37175000 usd
us-gaap Net Income Loss
NetIncomeLoss
827000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4586000 usd
us-gaap Depreciation
Depreciation
370000 usd
us-gaap Depreciation
Depreciation
113000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
269000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
177000 usd
PPSI Amortization Of Imputed Interest
AmortizationOfImputedInterest
-321000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
514000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
495000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
80000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-140000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1246000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
859000 usd
us-gaap Other Noncash Income
OtherNoncashIncome
15000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1805000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1253000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-468000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4319000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2990000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-167000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-4000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
24000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2407000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1141000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-4685000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
4198000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-520000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-491000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-228000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3936000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2345000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
391000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2345000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-391000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
50000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
17000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
177000 usd
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
73000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
296000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
179000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-142000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-162000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2715000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4489000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10296000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11699000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7581000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7210000 usd
PPSI Acquisition Of Right Of Use Assets And Lease Liabilities
AcquisitionOfRightOfUseAssetsAndLeaseLiabilities
551000 usd
PPSI Deferred Financing Costs Included In Accounts Payable And Accrued Liabilities
DeferredFinancingCostsIncludedInAccountsPayableAndAccruedLiabilities
122000 usd
PPSI Surrender And Retirement Of Common Stock
SurrenderAndRetirementOfCommonStock
720000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
17010000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1311000 usd
CY2022Q3 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
143000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
15842000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
17684000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1024000 usd
CY2023Q3 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
285000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
50000 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
177000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
720000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
18499000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
19552000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4586000 usd
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
859000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
17000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
15842000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
16933000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
16933000 usd
us-gaap Net Income Loss
NetIncomeLoss
827000 usd
us-gaap Net Income Loss
NetIncomeLoss
827000 usd
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
1246000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
50000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
177000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
720000 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
-14000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
18499000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
18499000 usd
PPSI Number Of Additional Locations
NumberOfAdditionalLocations
3 location
CY2022 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segments
CY2023Q3 PPSI Deferred Tax Assets Valuation Allowance Percentage
DeferredTaxAssetsValuationAllowancePercentage
1 pure
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7581000 usd
CY2023Q3 PPSI Working Capital Deficit
WorkingCapitalDeficit
13702000 usd
CY2023Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
7500000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.75
PPSI Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Granted
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted
575000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
225000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
4.97
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
1119000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
125000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
4.35
CY2023Q3 us-gaap Costs Incurred Development Costs
CostsIncurredDevelopmentCosts
6408000 usd
CY2022Q3 us-gaap Costs Incurred Development Costs
CostsIncurredDevelopmentCosts
2100000 usd
us-gaap Costs Incurred Development Costs
CostsIncurredDevelopmentCosts
13195000 usd
us-gaap Costs Incurred Development Costs
CostsIncurredDevelopmentCosts
2881000 usd
CY2023Q3 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
2569000 usd
CY2022Q3 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
81000 usd
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
8336000 usd
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
2137000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12443000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6251000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33080000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17476000 usd
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
543000 usd
CY2023Q3 PPSI Stock Issued During Period Shares Issued For Services Fair Value
StockIssuedDuringPeriodSharesIssuedForServicesFairValue
10000 shares
PPSI Stock Issued During Period Shares Issued For Services Fair Value
StockIssuedDuringPeriodSharesIssuedForServicesFairValue
10000 shares
CY2023Q3 PPSI Stock Issued During Period Value Issued For Services Fair Value
StockIssuedDuringPeriodValueIssuedForServicesFairValue
64900000 usd
PPSI Stock Issued During Period Value Issued For Services Fair Value
StockIssuedDuringPeriodValueIssuedForServicesFairValue
64900000 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
285000 usd
CY2023Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
6808000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2962000 usd
CY2023Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
1472000 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
5786000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
8280000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
8748000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6319000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3974000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2544000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2174000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3775000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1800000 usd
CY2023Q3 us-gaap Depreciation
Depreciation
143000 usd
CY2022Q3 us-gaap Depreciation
Depreciation
40000 usd
us-gaap Depreciation
Depreciation
370000 usd
us-gaap Depreciation
Depreciation
113000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4961000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5615000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4811000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1624000 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
9772000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7239000 usd
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3500000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
0 usd
CY2023Q3 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
366000 usd
CY2022Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
278000 usd
CY2023Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
312000 usd
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
213000 usd
CY2023Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
30000 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
258000 usd
CY2023Q3 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
0 usd
CY2022Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
559000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
670667 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.45
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
97500 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.80
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
15000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.31
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
35000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.60
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
718167 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.53
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y8M12D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1056000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
623167 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.50
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y1M6D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
983000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
250000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
4.35
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
1087000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
100000 shares
us-gaap Share Based Compensation
ShareBasedCompensation
1246000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
143000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
859000 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
638000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y1M6D
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1024000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1311000 usd
us-gaap Net Income Loss
NetIncomeLoss
827000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4586000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10010226 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9769545 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9896850 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9713335 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
239873 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
152159 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10250099 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9769545 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10049009 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9713335 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.47
CY2023Q3 us-gaap Revenues
Revenues
12443000 usd
CY2022Q3 us-gaap Revenues
Revenues
6251000 usd
us-gaap Revenues
Revenues
33080000 usd
us-gaap Revenues
Revenues
17476000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
207000 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
94000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
639000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
290000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
953000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1444000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
631000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4789000 usd

Files In Submission

Name View Source Status
ppsi-20230930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001493152-23-041076-index-headers.html Edgar Link pending
0001493152-23-041076-index.html Edgar Link pending
0001493152-23-041076.txt Edgar Link pending
0001493152-23-041076-xbrl.zip Edgar Link pending
ex10-3.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
ppsi-20230930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ppsi-20230930_def.xml Edgar Link unprocessable
ppsi-20230930_lab.xml Edgar Link unprocessable
ppsi-20230930_pre.xml Edgar Link unprocessable
form10q_htm.xml Edgar Link completed